| Code | 34060 | ||||||||||
| MA number | 42/0232/02-S | ||||||||||
| Product Form: | tbl 35x125 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Berlin-Chemie AG, Germany | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 30.10.2002 |
| Pediatric contraindication: | Yes |
| PIL: |
PIL_Zovudex 125 mg tbl_04.2021.pdf
|
| SPC: |
SPC_Zovudex 125 mg tbl_04.2021.pdf
|
| Safety feature | Yes |
| Data update: | 27.07.2018 |
